Search
Publication
Countering online vaccine misinformation in the EU/EEA
This study provides insights for national public health authorities into the factors behind the spread of vaccine misinformation online and the options and capacities needed for responding to it.
Data
Evidence of the immunogenicity of HPV vaccines in males
New evidence on efficacy, immunogenicity and safety of HPV vaccines for boys/men
Data
Evidence of the safety of the HPV vaccines in males
Efficacy/effectiveness, immunogenicity, safety and tolerability of the HPV vaccines in males
Data
Evidence of the efficacy of the 9vHPV vaccine
Efficacy/effectiveness, immunogenicity, safety and tolerability of the 9-valent HPV vaccine.
Data
Evidence of the immunogenicity of the 9vHPV vaccine
Efficacy/effectiveness, immunogenicity, safety and tolerability of the 9-valent HPV vaccine
Data
Evidence of the safety of the 9vHPV vaccine
Efficacy/effectiveness, immunogenicity, safety and tolerability of the 9-valent HPV vaccine.
Data
Evidence of the immunogenicity of the HPV vaccine in HIV-infected men and women
Efficacy, immunogenicity, safety and tolerability in other populations not previously targeted by immunisation programmes: HIV-infected
Data
Evidence of the safety of the HPV vaccine in HIV-infected men and women
Efficacy, immunogenicity, safety and tolerability in other populations not previously targeted by immunisation programmes: HIV-infected men and women
Publication
Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.